Two Seas Capital
LUCD icon

Two Seas Capital’s Lucid Diagnostics LUCD Stock Holding History

Two Seas Capital’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.51M Hold
6,000,000
– – 0.05% 40
2026
Q2 		$6.42M Buy
6,000,000
+3,000,000
+100% +$3.23M 0.13% 41
2026
Q1 		$3.45M Hold
3,000,000
– – 0.05% 43
2025
Q4 		$3.27M Hold
3,000,000
– – 0.07% 36
2025
Q3 		$3.03M Buy
+3,000,000
New +$3.28M 0.05% 38

Other funds holding LUCD

TIA
Traphagen Investment Advisors Oradell, New Jersey $1.46B AUM 14.92% 1-Year Est. Return
Sax Wealth Advisors
Sax Wealth Advisors Parsippany, New Jersey $3.5B AUM 13.73% 1-Year Est. Return
AP
Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Two Seas Capital's LUCD Position: Q3 2026 in Review

Two Seas Capital held its Lucid Diagnostics (LUCD) position steady in Q3 2026 at 6,000,000 shares worth $4.51M. The position accounts for 0.05% of the portfolio, ranked #40.

Two Seas Capital first reported a position in LUCD in Q3 2025 and has held it in 5 quarters since. The position peaked at $6.42M in Q2 2026. 10 funds tracked by Wall St. Rank hold LUCD as of Q3 2026.

  • Two Seas Capital held 6,000,000 shares of Lucid Diagnostics worth $4.51M as of Q3 2026.
  • Two Seas Capital left its Lucid Diagnostics share count unchanged in Q3 2026.
  • Lucid Diagnostics made up 0.05% of Two Seas Capital's portfolio in Q3 2026, its #40 holding.
  • Two Seas Capital first reported a position in Lucid Diagnostics in Q3 2025 and has held it in 5 quarters since.
  • Two Seas Capital's Lucid Diagnostics position peaked at $6.42M in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2026.

Based on Two Seas Capital's 13F filing for Q3 2026, filed 6 Oct 2026.